CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma.

Jie SunXiaoquan ZhuYanyang ZhaoLiang SunRuomei QiHui Liu

Published in: Pharmacogenomics and personalized medicine (2021)

Our data indicate for the first time that high CHN1 expression is associated with favorable outcomes in DLBCL patients, suggesting its potential utility as a prognostic marker in DLBCL.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
poor prognosis
prognostic factors
peritoneal dialysis
type diabetes
big data
adipose tissue
patient reported outcomes
long non coding rna